Selasa, 14 Mei 2013
adulterated drugs
adverse effects
crime
Daiichi Sankyo
FDA
manufacturing problems
outsourcing
Ranbaxy
Six Years Later, Ranbaxy - Oops, Daiichi Sankyo - Pleads Guilty to Adulteration, Pays $500 Million
It only took until 2013, but the US Food and Drug Administration finally secured guilty pleas and fines. The basics are in an Associated Pr...